This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Illumina Launches VeriSeq PGS

Illumina, Inc. (NASDAQ:ILMN) today announced the launch of VeriSeq TM PGS, a next-generation sequencing (NGS) solution developed for preimplantation genetic screening (PGS) of embryos using Illumina’s NextSeqTM 500 and MiSeq® sequencing systems. The offering brings together the industry-leading Illumina 24sure array-based platform for PGS with Illumina’s next-generation sequencing (NGS) technology to offer laboratories a more scalable PGS solution.

“Bringing the high-throughput capabilities of Illumina’s NGS systems to PGS will enable IVF clinics to offer the latest technology to their patients,” said Simon Fishel, CEO of CARE Fertility Group. “VeriSeq PGS has the potential to improve pregnancy success rates for couples using IVF by identifying chromosomally normal embryos for implantation.”

PGS has been clinically proven as an effective means to select chromosomally normal embryos, increasing pregnancy success rates for in vitro fertilization (IVF) procedures. 1,2 VeriSeq PGS complements the 24sure array-based assay, using the same sample preparation and BlueFuse software workflows. The NGS-based assay leverages Illumina’s sequencing systems and enables reference laboratories to perform PGS using a platform that meets their throughput needs.

“VeriSeq PGS showed a high level of consistency with the established 24sure technology,” said Francesco Fiorentino, Ph.D., Founder and Lab Director, GENOMA Laboratory. “I recently did a comparison study between the 24sure assay and VeriSeq PGS to assess the accuracy of an NGS-based test for aneuploidy screening on single cells. NGS-based aneuploidy screening appears to be a robust methodology ready to find a place in routine clinical application.”

“VeriSeq PGS demonstrates Illumina’s continuing commitment to reproductive and genetic health. By developing and providing accessible tools to perform PGS, we hope to enable reference laboratories to offer these services worldwide,” said Tristan Orpin, Senior Vice President and General Manager of Reproductive and Genetic Health for Illumina. “We want to offer these groups a complete reproductive health portfolio so they can better support physicians and their patients in pursuit of successful pregnancies.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs